Karnataka FDA concerned over lack of guidelines for tattoo ink which causes skin diseases, viral & bacterial infections: Nandita Vijayasimha, Bengaluru Wednesday, March 5, 2025, 0 ...

Punjab FDA directs zonal officers to track manufacture and sale of seven H and H1 drugs: Peethaambaran Kunnathoor, Chennai Wednesday, March 5, 2025, 08:00 Hrs [IST] Following info ...

Dr Badami and Dr Mrutyunjaya: Nandita Vijayasimha, Bengaluru Wednesday, March 5, 2025, 08:00 Hrs [IST] Pharmacy is increa ...

Hrs [IST] Recently, while considering a case where the handwriting of the doctor in the medico-legal report was ...

DGFT eases compliance burden as pharma exporters face hurdles in advance authorisation closure: Shardul Nautiyal, Mumbai Wednesday, March 5, 2025, 08:00 Hrs [IST] The Directorate ...

Neovantage Innovation Park showcases life sciences infrastructure at BioAsia 2025, hosts ministerial visit and Miltenyi ...

Karnataka government appoints Dr B R Jagashetty as special resource officer to the state FDA: Our Bureau, Bengaluru Tuesday, ...

AbbVie and Gubra ink license agreement to develop an amylin analog for the treatment of obesity: North Chicago, Illinois Tuesday, March 4, 2025, 10:00 Hrs [IST] AbbVie and Gubra A ...

Wipro GE Healthcare launches ‘AI Enabled - Made in India’ ultrasound system - Versana Premier R3: Our Bureau, Mumbai Tuesday, March 4, 2025, 15:50 Hrs [IST] Wipro GE Healthcar ...

US FDA accepts for review GSK’s BLA for depemokimab for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps: London, UK Tuesday, March 4, 2025, 09:0 ...

Positive results from the Tezspire phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps: Cambridge, UK Tuesday, March 4, 2025, ...

Senores Pharmaceuticals acquires 14 ANDAs from Dr Reddy’s Laboratories: Our Bureau, Bengaluru Tuesday, March 4, 2025, 17:15 Hrs [IST] Senores Pharmaceuticals through its wholly- ...